Clinical trial
Trial to Assess Efficacy and Safety of Lacosamide in Subjects With…
NCT00485472 · UCB Pharma, Industry · Terminated
Key facts
| NCT number | NCT00485472 |
|---|---|
| Title | Trial to Assess Efficacy and Safety of Lacosamide in Subjects With Osteoarthritis of the Knee |
| Official title | A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Osteoarthritis of the Knee |
| Lead sponsor | UCB Pharma, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Osteoarthritis |
| Intervention type | Drug, Other |
| Interventions | lacosamide, Placebo |
| Enrollment | 194 |
| Start date | Mar 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Jun 13, 2007 |
| Last update posted | Aug 28, 2017 |
| Countries | Czechia, Germany, Hungary, Poland, Romania, Sweden, United Kingdom |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: